AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3035878
Drug: Maprotiline, 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maprotiline, 75 mg, b.i.d., n = 35
Trial: 29196928
Drug: L-thyroxine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-thyroxine treatment (LT4 group)
Trial: 16214379
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy vs Exercise therapy
Trial: 15330820
Drug: Indomethacin 100
RxNorm normalized name: indomethacin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 100 mg intramuscularly
Trial: 9203174
Drug: Steroid-resistant nephrotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid-resistant nephrotic syndrome
Trial: 3275568
Drug: Rifampin (300-450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampin (300-450 mg/day)
Trial: 30109672
Drug: HD-MA (high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HD-MA (high-dose methotrexate plus cytarabine)
Trial: 11264734
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (untreated)
Trial: 12359687
Drug: Olanzapine augmentation
RxNorm normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olanzapine augmentation for 8 weeks
Trial: 12359687
Drug: Placebo administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administration for 8 weeks
Trial: 23460714
Drug: Docetaxel plus
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel plus gefitinib 250 mg/d, orally (arm B)
Trial: 10941967
Drug: Partially vegetable
RxNorm normalized name: Hydrogenated Vegetable Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Partially vegetable fat milk (3.5 g/dL fat; 50% vegetable fat: rapeseed oil)
Trial: 10941967
Drug: Full vegetable-fat
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full vegetable-fat milk (3.5 g/dL fat; 100% vegetable fat: palm, coconut, and soy oil)
Trial: 10941967
Drug: Standard-fat milk
RxNorm normalized name: MILK FAT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-fat milk (3.5 g/dL cow's milk fat)
Trial: 8473716
Drug: Imipramine 150
RxNorm normalized name: imipramine pamoate 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine 150 mg/day
Trial: 7734470
Drug: Imipramine 10
RxNorm normalized name: trimipramine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine 10 mg/day (control)
Trial: 25632806
Drug: Pinaverium (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pinaverium (50 mg, 3 times/day)
Trial: 15116084
Drug: Red carrots
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red carrots (5 mg/day)
Trial: 15116084
Drug: Tomato paste
RxNorm normalized name: Tomato
DrugBank: Tomato (DB10573)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tomato paste (5 mg/day)
Trial: 15116084
Drug: Tomato paste
RxNorm normalized name: Tomato
DrugBank: Tomato (DB10573)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tomato paste plus white carrots (5 mg/day)
Trial: 11297716
Drug: Cognitive intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive intervention designed to reduce anxiety/distress responses to the doxapram injection
Trial: 1903918
Drug: Flecainide (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flecainide (0.15 mg.kg‐1.h‐1 after a loading dose of 2 mg.kg‐1)
Trial: 1903918
Drug: Digoxin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digoxin (10 micrograms.kg‐1 for 12 hours, then 0.25 mg.24 h‐1)
Trial: 26363825
Drug: Mifepristone (25mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone (25mg every 12h for 3 days and 600μg buccal misoprostol on the morning of the fourth day)
Trial: 20939675
Drug: N-acetyl cysteine
RxNorm normalized name: N-Acetyl Cysteine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetyl cysteine (NAC) plus clomiphene citrate (CC)
Trial: 20939675
Drug: Metformin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin plus clomiphene citrate (CC)
Trial: 15163387
Drug: Perindopril treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril treatment group
Trial: 6761890
Drug: Aspirin and
RxNorm normalized name: Aspirin and Caffeine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin and dipyridamole (ASA + DPM)
Trial: 6761890
Drug: Aspirin and
RxNorm normalized name: Aspirin and Caffeine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin and dipyridamole (ASA + DPM) post-operative therapy
Trial: 27231549
Drug: Four-drug combination
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four-drug combination therapy (low-dose tacrolimus, low-dose mycophenolate mofetil, corticosteroids, and mizoribine)
Trial: 27231549
Drug: Three-drug combination
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-drug combination therapy (tacrolimus, mycophenolate mofetil, and corticosteroids)
Trial: 7671566
Drug: High sodium
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High sodium intake (260 mmol/day) with arginine vasopressin infusion (2 fmol min‐1 kg‐1)
Trial: 7671566
Drug: Low sodium
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low sodium intake (20 mmol/day) with arginine vasopressin infusion (2 fmol min‐1 kg‐1)
Trial: 2111414
Drug: Administration of
RxNorm normalized name: IV solutions used in parenteral administration of fluids, electrolytes and nutrients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Administration of PSK
Trial: 7244752
Drug: Subcutaneous epinephrine
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous epinephrine (various doses)
Trial: 7244752
Drug: Optimal epinephrine
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Optimal epinephrine therapy
Trial: 30552589
Drug: Articaine group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Articaine group - inferior alveolar nerve block with lignocaine (2%) adrenaline (1:80000) + Buccal infiltration with articaine (4%) with adrenaline (1:100000)
Trial: 27538109
Drug: Silicone gel
RxNorm normalized name: SILTREX Silicone Gel-Pad
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silicone gel sheeting applied to one foot scar for 12 weeks
Trial: 24433223
Drug: heparin
RxNorm normalized name: Heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: heparin
Trial: 20513728
Drug: resolution of
RxNorm normalized name: Revolution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: resolution of ST elevation in aVR to <1 mm after fibrinolytic therapy
Trial: 20513728
Drug: new ST
RxNorm normalized name: BENZALKONIUM CHLORIDE 1 g in 500 mL EXTRACORPOREAL LIQUID [BZK NEW STERILIZATION FORMULA AITI-BACTERIAL MULTI-PURPOSESPRAY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: new ST elevation > or =1 mm after fibrinolytic therapy
Trial: 11004863
Drug: Mitogenic stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mitogenic stimulation of peripheral blood lymphocytes by PHA (1 microgram/ml)
Trial: 11777366
Drug: High doses
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High doses of prednisone
Trial: 23126609
Drug: Butorphanol (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butorphanol (0.1 mg/kg bwt)
Trial: 23126609
Drug: Butorphanol (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butorphanol (0.05 mg/kg bwt)
Trial: 6814669
Drug: Saline (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (0.5 ml)
Trial: 19501213
Drug: Oral contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptives (both high and low estrogen)
Trial: 15567797
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Fu needling and electric acupuncture
Trial: 11028934
Drug: Oral ganciclovir
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ganciclovir prophylaxis
Trial: 8310723
Drug: Intravenous amino
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous amino acid mixture (10 g/h)
Trial: 8283363
Drug: Orally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orally administered placebo
Trial: 8283363
Drug: Nebulized albuterol
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized albuterol (in recurrent wheezing group)
Trial: 8283363
Drug: Orally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orally administered albuterol
Trial: 8283363
Drug: Nebulized saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized saline solution
Trial: 3051529
Drug: Identical-appearing placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Identical-appearing placebo tablets twice daily for up to 3 years
Trial: 11441422
Drug: Ecopipam (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ecopipam (100 mg p.o.)
Trial: 9743296
Drug: Reinduction therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reinduction therapy with the same cytostatic treatment (5-FU/LV or 5-FU/LLV) administered at 100 mg m(‐2) day(‐1) by i.v. bolus injection, followed by 5-FU 400 mg m(‐2) day(‐1) given as a 2-h infusion for 5 consecutive days at 4-week intervals x 6 or until tumor progression.
Trial: 24131861
Drug: Focal psychodynamic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Focal psychodynamic therapy
Trial: 25865660
Drug: Standard portion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard portion size of ice cream
Trial: 25865660
Drug: Larger portion
RxNorm normalized name: Bos taurus large intestine preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Larger portion size of ice cream
Trial: 21112641
Drug: Antenatal intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antenatal intervention (nine‐unit self‐guided workbook with weekly telephone support)
Trial: 17380232
Drug: RIX4414 live
RxNorm normalized name: HUMAN ROTAVIRUS A TYPE G1P(8) STRAIN RIX4414 LIVE ANTIGEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RIX4414 live attenuated human rotavirus vaccine (10^5.8 FFU)
Trial: 14997172
Drug: Continuation treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuation treatment with mirtazapine
Trial: 11711508
Drug: Felodipine (2.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine (2.5, 5, or 10 mg once daily)
Trial: 9025120
Drug: Biological parents
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biological parents of ADHD boys
Trial: 9025120
Drug: Biological parents
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biological parents of comparison boys
Trial: 3414992
Drug: 0.5% tetracaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% tetracaine (15 mg)
Trial: 3414992
Drug: 0.5% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% bupivacaine (15 mg)
Trial: 29649764
Drug: Intranasal progesterone
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intranasal progesterone (9 mg MPP22)
Trial: 29649764
Drug: Intranasal progesterone
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intranasal progesterone (4.5 mg MPP22)
Trial: 23613962
Drug: Carvedilol (CARV)
RxNorm normalized name: Carvedilol
DrugBank: Carvedilol (DB01136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carvedilol (CARV) after saline infusion
Trial: 12600850
Drug: Control meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control meal (energy-free soup with 50 g carbohydrate)
Trial: 11268452
Drug: Cisplatin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (5 x 20 mg/m2) over 5 days
Trial: 11268452
Drug: Cisplatin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (1 x 50 mg/m2) plus ifosfamide (4 g/m2) as a single-day infusion
Trial: 11268452
Drug: High-dose chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose chemotherapy with carboplatin (3 x 500 mg/m2) and ifosfamide (3 x 4 g/m2) over three days
Trial: 27832753
Drug: Oxytocin augmentation
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin augmentation
Trial: 29096522
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine by infusion
Trial: 19455984
Drug: Ozone therapy
RxNorm normalized name: ozone
DrugBank: Ozone (DB12510)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ozone therapy
Trial: 15115904
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (carvedilol + enalapril)
Trial: 12239447
Drug: Vinblastine (VBL)
DrugBank: Vinblastine (DB00570)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vinblastine (VBL) 0.15 mg/kg i.v. every 2 weeks and Interferon-gamma (IFN-gamma) 100 microg s.c. 3 times weekly (Trial 1)
Trial: 12239447
Drug: Vinblastine (VBL)
DrugBank: Vinblastine (DB00570)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vinblastine (VBL) 0.15 mg/kg i.v. every 2 weeks, Interferon-gamma (IFN-gamma) 100 microg s.c. 3 times weekly, and oral 13-cis retinoic acid (13-CRA) 40 mg/day (Trial 2)
Trial: 8960727
Drug: Oral 3,4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral 3,4 diaminopyridine (DAP)
Trial: 1561829
Drug: Split-product influenza
RxNorm normalized name: INFLUENZA VIRUS (SPLIT) VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Split-product influenza vaccine in full-term children
Trial: 30366845
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy trials with funding, conducted in Europe and Oceania, and with a Physiotherapy Evidence Database score of at least 6/10
Trial: 30366845
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy trials
Trial: 24928639
Drug: 6 sessions
RxNorm normalized name: Alpinia Sessilis Root
DrugBank: Kaempferia galanga root (DB14288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 sessions of spinal manipulative therapy (SMT)
Trial: 25533998
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg ramelteon
Trial: 17373561
Drug: Integrated Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrated Cognitive Behavioral Treatment (ICBT)
Trial: 20455882
Drug: Everolimus 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Everolimus 1.5 mg/day with reduced-exposure CsA
Trial: 20455882
Drug: Everolimus 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Everolimus 3.0 mg/day with reduced-exposure CsA
Trial: 20455882
Drug: Mycophenolic acid
RxNorm normalized name: mycophenolic acid
DrugBank: Mycophenolic acid (DB01024)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mycophenolic acid (MPA) 1.44 g/day plus standard-exposure CsA
Trial: 12142815
Drug: Ranitidine 5
RxNorm normalized name: ranitidine 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 5 mg/kg daily
Trial: 12142815
Drug: Ranitidine 10
RxNorm normalized name: ranitidine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 10 mg/kg daily
Trial: 9663727
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg daily
Trial: 973959
Drug: Pindolol (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol (5 mg)
Trial: 15933496
Drug: Local corticosteroid
RxNorm normalized name: Corticosteroids acting locally
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local corticosteroid injection
Trial: 30204859
Drug: Intensive nutritional
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive nutritional intervention (weekly dietetic consultation, energy-protein-enriched diet, and ONS 400 mL per day for 3 months)
Trial: 26576820
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment (cognitive behavior therapy and fluoxetine)
Trial: 2220335
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of radiographic techniques
Trial: 366350
Drug: Intranasal beclomethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal beclomethasone dipropionate (300 microgram/day)
Trial: 28922519
Drug: Olive oil
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olive oil treatment
Trial: 28922519
Drug: HOFA treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HOFA treatment
Trial: 20502929
Drug: L. paracasei
RxNorm normalized name: L. paracasei/L. rhamnosus 11 billion cell ORAL CAPSULE
DrugBank: Lactobacillus paracasei (DB16551)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L. paracasei GMNL‐33
Trial: 19905943
Drug: Periodontal treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Periodontal treatment (scaling and root planing) before 21 weeks of gestation
Trial: 17970675
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (periodontal treatment after delivery)
Trial: 30569067
Drug: Native whey
RxNorm normalized name: whey protein hydrolysate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Native whey (20 g)
Trial: 30569067
Drug: WPC‐80 (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WPC‐80 (20 g)
Trial: 15602190
Drug: Albendazole (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albendazole (15 mg/kg/day twice a day for 7 days)
Trial: 24449228
Drug: SRP and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRP and oral doxycycline (100 mg) administration once daily for 15 days
Trial: 16580190
Drug: Urokinase (125,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urokinase (125,000 UI) administered via intrathoracic tube every 12 hours until pleural fluid < 50 cm3
Trial: 16580190
Drug: Urokinase (125,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urokinase (125,000 UI) administered via intrathoracic tube
Trial: 10784638
Drug: Dexamethasone 2
RxNorm normalized name: dexamethasone 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 2 mg orally three times a day (tid)
Trial: 8729590
Drug: Fluvastatin 40
RxNorm normalized name: fluvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 40 mg twice daily, starting at least 2 weeks before PTCA
Trial: 1343609
Drug: Ciprofloxacin (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (250 mg daily for 6 months)
Trial: 1343609
Drug: Trimethoprim-sulfamethoxazole (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim-sulfamethoxazole (80 mg trimethoprim, 400 mg sulfamethoxazole daily for 6 months)
Trial: 8527269
Drug: MK-0591 (125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-0591 (125 mg twice daily for 9.5 days)
Trial: 8527269
Drug: MK-0591 (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-0591 (250 mg single dose)
Trial: 28659234
Drug: Ginger (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginger (250 mg ginger capsules from the onset of menstruation)
Trial: 25835438
Drug: High-Intensity Statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-Intensity Statin Therapy (HIST)
Trial: 25835438
Drug: Low-Intensity Statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-Intensity Statin Therapy (LIST)
Trial: 25835438
Drug: No-Statin Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No-Statin Therapy
Trial: 15138463
Drug: 15 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g/day alcohol
Trial: 15138463
Drug: 30 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g/day alcohol
Trial: 15138463
Drug: 0 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g/day alcohol (control)
Trial: 11477813
Drug: Purified Xuefu
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purified Xuefu Capsule (PXFC) and western medicine
Trial: 11477813
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine (isosorbide dinitrate, diltiazem or atenolol)
Trial: 11477813
Drug: Purified Xuefu
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purified Xuefu Capsule (PXFC)
Trial: 667231
Drug: Haloperidol (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (0.5 mg injection)
Trial: 27678433
Drug: Oral-fat tolerance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral-fat tolerance test (OFTT)
Trial: 27678433
Drug: Oral-fat tolerance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral-fat tolerance test (OFTT) in CORDIOPREV study
Trial: 23877305
Drug: Single shot
RxNorm normalized name: ACL7 SINGLE SHOT EPIDURAL KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single shot femoral nerve block (FNB) using 15mL bupivacaine 0.25% and 20 mg clonidine